EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Functional Characterization of Pathway Inhibitors for the Ubiquitin-Proteasome System (UPS) as Tool Compounds for CRBN and VHL-Mediated Targeted Protein Degradation

Martin P Schwalm iD, Amelie Menge, Lewis Elson, Francesco A Greco iD, Matthew B Robers, Susanne Müller iD, Stefan Knapp iD

ACS Chemical Biology · 2025

DOI: 10.1021/acschembio.4c00450 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Biology, 2025. Verfasst von Martin P Schwalm und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institut für Pharmazeutische Chemie, Goethe-University Frankfurt, Biozentrum, Max-von-Laue-Str. 9, 60438 Frankfurt am Main, Germany. Hauptthemen laut MEDLINE: Von Hippel-Lindau Tumor Suppressor Protein, Proteasome Endopeptidase Complex, Proteolysis, Ubiquitin. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bayer, Deutsches Krebsforschungszentrum, Genentech.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Von Hippel-Lindau Tumor Suppressor ProteinProteasome Endopeptidase ComplexProteolysisUbiquitinHumansUbiquitin-Protein LigasesAdaptor Proteins, Signal TransducingProteasome Inhibitors

Substanzen

Von Hippel-Lindau Tumor Suppressor ProteinProteasome Endopeptidase ComplexUbiquitinVHL protein, humanCRBN protein, humanUbiquitin-Protein LigasesAdaptor Proteins, Signal TransducingProteasome Inhibitors

Autor:innen und Institutionen

  • Institut für Pharmazeutische Chemie, Goethe-University Frankfurt, Biozentrum, Max-von-Laue-Str. 9, 60438 Frankfurt am Main, Germany.
  • Structural Genomics Consortium, Goethe-University Frankfurt, Buchmann Institute for Life Sciences, Max-von-Laue-Str. 15, 60438 Frankfurt am Main, Germany.
  • German Cancer Consortium (DKTK)/German Cancer Research Center (DKFZ), DKTK site Frankfurt-Mainz, 69120 Heidelberg Germany.
  • Promega Corporation, Madison, Wisconsin 53711, United States.

ORCID-Profile: Martin P Schwalm, Francesco A Greco, Susanne Müller, Stefan Knapp

Förderung

  • Bayer
  • Deutsches Krebsforschungszentrum
  • Genentech
  • Takeda Foundation
  • Deutsche Forschungsgemeinschaft
  • Pfizer
  • Innovative Medicines Initiative
  • Bristol-Myers Squibb

Zitieren

APA

Schwalm, M. P., Menge, A., Elson, L., Greco, F. A., Robers, M. B., Müller, S., & Knapp, S. (2025). Functional Characterization of Pathway Inhibitors for the Ubiquitin-Proteasome System (UPS) as Tool Compounds for CRBN and VHL-Mediated Targeted Protein Degradation. ACS Chemical Biology. https://doi.org/10.1021/acschembio.4c00450

Vancouver

Schwalm MP, Menge A, Elson L, Greco FA, Robers MB, Müller S, et al. Functional Characterization of Pathway Inhibitors for the Ubiquitin-Proteasome System (UPS) as Tool Compounds for CRBN and VHL-Mediated Targeted Protein Degradation. ACS Chemical Biology. 2025. doi:10.1021/acschembio.4c00450

BibTeX
@article{Schwalm2025,
  author = {Schwalm, Martin P and Menge, Amelie and Elson, Lewis and Greco, Francesco A and Robers, Matthew B and Müller, Susanne and Knapp, Stefan},
  title = {Functional Characterization of Pathway Inhibitors for the Ubiquitin-Proteasome System (UPS) as Tool Compounds for CRBN and VHL-Mediated Targeted Protein Degradation},
  journal = {ACS Chemical Biology},
  year = {2025},
  doi = {10.1021/acschembio.4c00450}
}
Kostenlos starten →